ROPIVACAINE HYDROCHLORIDE INJECTION, USP
FRESENIUS KABI CANADA LTD
Quick answers
Is there a shortage of ROPIVACAINE HYDROCHLORIDE INJECTION, USP in Canada?
No. There is no current shortage of ROPIVACAINE HYDROCHLORIDE INJECTION, USP 2MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ROPIVACAINE HYDROCHLORIDE INJECTION
TEVA CANADA LIMITED
Other Products
XFUSOR
FORMATIVE PHARMA INC.
NAROPIN
ASPEN PHARMACARE CANADA INC.
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
FRESENIUS KABI CANADA LTD
NAROPIN INJ 7.5MG/ML
ASTRAZENECA CANADA INC
DIN
02439379
Strength
2MG
Dosage Form
SOLUTION
Route
EPIDURAL INFILTRATION
Compare with another product →
Shortage History
Demand increase for the drug.
Other (Please describe in comments)
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02457482
3MG · DIN 02267659
3MG · DIN 02457474
50MG · DIN 02245248
250MG · DIN 02227029
2G · DIN 02226995
1G · DIN 02227002